Atlas Trials

Omitting CTV for Locally Advanced NSCLC Responded to Immunotherapy and Chemotherapy

Clinical trial NCT06020430 · RECRUITING

Trial details

NCT number
NCT06020430
Sponsor
Hubei Cancer Hospital
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Non Small Cell Lung CancerLocally AdvancedRadiotherapyImmunotherapy
Start date
2024-02-08
Primary completion
2026-02-08
Enrollment
134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.